These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9799710)

  • 1. The complement system and adaptive immunity.
    Fearon DT
    Semin Immunol; 1998 Oct; 10(5):355-61. PubMed ID: 9799710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.
    Fearon DT; Carroll MC
    Annu Rev Immunol; 2000; 18():393-422. PubMed ID: 10837064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
    Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
    J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD22 regulates thymus-independent responses and the lifespan of B cells.
    Otipoby KL; Andersson KB; Draves KE; Klaus SJ; Farr AG; Kerner JD; Perlmutter RM; Law CL; Clark EA
    Nature; 1996 Dec 19-26; 384(6610):634-7. PubMed ID: 8967951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CD22 and other inhibitory co-receptors in B-cell activation.
    Nitschke L
    Curr Opin Immunol; 2005 Jun; 17(3):290-7. PubMed ID: 15886119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the complement C3 protein in the control of the specific immune response].
    Villiers CL; Villiers MB; Marche PN
    Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
    Fearon DT; Carter RH
    Annu Rev Immunol; 1995; 13():127-49. PubMed ID: 7542009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
    Rickert RC
    Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD21 augments antigen presentation in immune individuals.
    Boackle SA; Holers VM; Karp DR
    Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.
    Sato S; Tuscano JM; Inaoki M; Tedder TF
    Semin Immunol; 1998 Aug; 10(4):287-97. PubMed ID: 9695185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of B lymphocytes: integrating signals from CD19, CD22 and Fc gamma RIIb1.
    Doody GM; Dempsey PW; Fearon DT
    Curr Opin Immunol; 1996 Jun; 8(3):378-82. PubMed ID: 8793993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
    Tedder TF; Poe JC; Fujimoto M; Haas KM; Sato S
    Curr Dir Autoimmun; 2005; 8():55-90. PubMed ID: 15564717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.
    Poe JC; Fujimoto Y; Hasegawa M; Haas KM; Miller AS; Sanford IG; Bock CB; Fujimoto M; Tedder TF
    Nat Immunol; 2004 Oct; 5(10):1078-87. PubMed ID: 15378059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
    Smith AJ; Gordon TP; Macardle PJ
    Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation.
    Holers VM; Kulik L
    Mol Immunol; 2007 Jan; 44(1-3):64-72. PubMed ID: 16876864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling.
    Gerlach J; Ghosh S; Jumaa H; Reth M; Wienands J; Chan AC; Nitschke L
    Eur J Immunol; 2003 Dec; 33(12):3418-26. PubMed ID: 14635051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLP-76 is recruited to CD22 and dephosphorylated by SHP-1, thereby regulating B cell receptor-induced c-Jun N-terminal kinase activation.
    Mizuno K; Tagawa Y; Watanabe N; Ogimoto M; Yakura H
    Eur J Immunol; 2005 Feb; 35(2):644-54. PubMed ID: 15668918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and signalling functions of C3 receptors on human B cells.
    Frade R
    Semin Immunol; 1990 Mar; 2(2):159-64. PubMed ID: 2151800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement's participation in acquired immunity.
    Nielsen CH; Leslie RG
    J Leukoc Biol; 2002 Aug; 72(2):249-61. PubMed ID: 12149415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
    Samardzic T; Gerlach J; Muller K; Marinkovic D; Hess J; Nitschke L; Wirth T
    Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.